Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02854436
Title An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC

prostate cancer



Age Groups: senior | adult
Covered Countries USA | FRA | ESP | CAN | BEL

No variant requirements are available.